By Scott Johnson
BIRMINGHAM – Blue Cross and Blue Shield of Alabama members who are moderately to severely immunocompromised will not have to pay for their third dose of the FDA authorized mRNA COVID-19 vaccination, the company announced on Wednesday, Aug. 25.
Blue Cross members on individual, Medicare and almost all employer health plans will be able to receive a FDA-authorized and CDC-recommended COVID-19 vaccine third dose without having to pay any out-of-pocket expenses.
The Centers for Disease Control and Prevention (CDC) recommend individuals with moderate to severely compromised immune systems receive a third dose of either the Pfizer or Moderna vaccine at least 28 days after their second dose.
See complete story in the Journal Record.